Kynurenine and tryptophan as surrogate immune suppression tumor biomarkers
While being neglected for decades, tumor immune escape is now considered as a new paradigm that promotes tumor growth and evasion. Besides the prototypical PD1 / PDL1 axis, several mechanisms have been identified as important actors in immune editing process. Indoleamine 2,3 dioxygenase (IDO1), a first rate-limiting enzyme of the Kynurenine pathway, has been described to favor tolerance and immune escape through the production of a series of metabolites, including L-Kynurenine. In this context, our ISE-2227 Kynurenine/tryptophan ELISA pack represents a powerfull tool to adress these metabolites.
Versatile Kynurenine/tryptophan level measurement and characterization of IDO1 inhibition. A. Microdialysates were collected from intratumoral vs. non-tumoral regions of tumor-bearing mice inoculated with the indicated tumor cell lines, for the determination of kynurenine to tryptophan ratio (KTR). As illutsrated, KTR is higher in tumor regions when compared to their respective non-tumor regions thus highlighting the participation of this pathway in tumor progression and eventually in immunotherapy resistance. Interestingly, MCA205-tumor bearing mice treated with an IDO inhibitor (Navoximod) displayed a significant decrease in KTR within the tumor. B. Mature human dendritic cells (mDCS) were cultured together with HLA-mismatched CD4+ T cells (mixed lymphocyte reaction context) and exposed for 72 hours with increasing concentrations of a reference IDO1 inhibitor. Supernatants were then collected for kynurenine and tryptophan content measurement by mean of ELISA (ISE-2227 Kynurenine/tryptophan ELISA pack). Kynurenine content (through KTR) is dose-dependently decreased by IDO inhibition.
Assessment of plasmatic kynurenine/tryptophan levels in cancer patients. A cohort of patients with various types of sarcomas were treated with immunotherapy (Pembrolizumab) and plasma were collected before (at cycle 1, day 8) and after (at cycle 2, day 8) the first infusion of pembrolizumab. Kynurenine and tryptophan plasma levels were measured by mean of ELISA (ISE-2227 Kynurenine/tryptophan IVD ELISA pack). A statistically significant increase in the kynurenine to tryptophan plasma ratio in patients during treatment was reported, underlying the role of the IDO1/kynurenine pathway in the resistance to PD-1/PD-L1 targeting in sarcomas (from Toulmonde et al., JAMA Oncology, Jan 2018).
To assess Kynurenine and Tryptophan levels in your samples,
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.Cookie SettingsAccept All
Manage consent
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.